GH Research PLC - Ordinary Shares (GHRS)
GHRS moved a median of -0.22% 30 minutes after news, and -1.08% by the close. How GHRS actually reacts to news — the realized, point-in-time move the market made, measured across 149 labeled events over the last three years with zero look-ahead.
GHRS’s median reaction, across the day.
| Horizon | Median | % positive | Events |
|---|---|---|---|
| 5-min | 0.00% | 39% | 146 |
| 30-min | -0.22% | 37% | 148 |
| 60-min | -0.25% | 43% | 149 |
| to close | -1.08% | 42% | 149 |
| Middle 50% of GHRS reactions | -2.24% to +1.22% |
|---|---|
| Median reaction (30-min) | -0.22% |
| Measured reactions | 149 |
Half of all GH Research PLC - Ordinary Shares news events land between -2.24% and +1.22% at 30 minutes.
Reaction stats as of 2026-09-21. Newest measured event . Reaction = percent move vs. the price at the news timestamp.
How GHRS reacts, by analyst action.
| Event | Events | Median 30-min | % positive | Median to close |
|---|---|---|---|---|
| Coverage initiations | 16 | -0.73% | 31% | -0.40% |
| Rating reiterations | 50 | +0.39% | 56% | -0.53% |
Last 3 years, pulled 2026-09-21. Reaction = percent move vs. the price at the news timestamp. Counts and medians only. The same measurement runs across every name in the dataset. 4 further classes were observed with fewer than 10 measured events and are not published. See how GHRS ranks against every other measured name →
That’s how GHRS usually reacts — get an email when it moves on news →Email me when GHRS moves on news.
One email per qualifying move — the headline, the measured reaction, and how it compares to GHRS's baseline. Nothing else.
Recent GHRS events, each with its measured reaction.
| Date | Headline | Event | Source | 5-min | To close |
|---|---|---|---|---|---|
| Form 6-K GH Research PLC For: Oct 09 | SEC filing · Form 6-K | SEC EDGAR | -0.77% | +2.18% | |
| Form 6-K GH Research PLC For: Sep 11 | SEC filing · Form 6-K | SEC EDGAR | +1.96% | -1.34% | |
| Form 6-K GH Research PLC For: Jun 30 | SEC filing · Form 6-K | SEC EDGAR | +0.72% | +4.43% | |
| GH Research Reports Second Quarter 2026 Financial Results and Provides Business Update | Press release | GlobeNewswire | +0.72% | +4.43% | |
| Form 6-K GH Research PLC For: Jun 26 | SEC filing · Form 6-K | SEC EDGAR | +0.42% | +12.52% | |
| Form 6-K GH Research PLC For: Jun 04 | SEC filing · Form 6-K | SEC EDGAR | -0.43% | -4.52% | |
| GH Research Announces Publication of Phase 2a Postpartum Depression Results | Press release | GlobeNewswire | -0.43% | -4.52% | |
| Form 6-K GH Research PLC For: May 21 | SEC filing · Form 6-K | SEC EDGAR | +0.09% | -2.81% | |
| Form EFFECT GH Research PLC | SEC filing · Form EFFECT | SEC EDGAR | +0.86% | +2.31% | |
| Form 6-K GH Research PLC For: Mar 31 | SEC filing · Form 6-K | SEC EDGAR | -2.41% | +3.25% | |
| Form 6-K GH Research PLC For: May 14 | SEC filing · Form 6-K | SEC EDGAR | -1.34% | -2.64% | |
| Form F-3 GH Research PLC | SEC filing · Form F-3 | SEC EDGAR | -2.41% | +3.25% | |
| GH Research Reports First Quarter 2026 Financial Results and Provides Business Update | Press release | GlobeNewswire | -2.41% | +3.25% | |
| Form 6-K GH Research PLC For: May 13 | SEC filing · Form 6-K | SEC EDGAR | +0.00% | +0.92% | |
| Form 6-K GH Research PLC For: Apr 30 | SEC filing · Form 6-K | SEC EDGAR | -1.56% | +0.88% | |
| GH Research Announces Pricing of $117.5 Million Underwritten Offering | Press release | GlobeNewswire | +1.41% | -3.48% | |
| GH Research Welcomes White House Executive Order to Accelerate Medical Treatments for Serious Mental Illness | Press release | GlobeNewswire | +3.08% | +0.28% | |
| Form 6-K GH Research PLC For: Mar 25 | SEC filing · Form 6-K | SEC EDGAR | -0.63% | -2.21% | |
| GH Research Announces Publication of Phase 2b Results for Mebufotenin (GH001) in JAMA Psychiatry and Reports New Finding of Severity-Independent Efficacy in TRD | Press release | GlobeNewswire | +0.85% | -1.37% | |
| Form 6-K GH Research PLC For: Mar 16 | SEC filing · Form 6-K | SEC EDGAR | -0.66% | +0.40% | |
| Form 20-F GH Research PLC For: Dec 31 | SEC filing · Form 20-F | SEC EDGAR | +0.00% | -4.89% | |
| Form 6-K GH Research PLC For: Mar 05 | SEC filing · Form 6-K | SEC EDGAR | +0.00% | -4.89% | |
| Form S-8 GH Research PLC | SEC filing · Form S-8 | SEC EDGAR | +0.00% | -4.89% | |
| GH Research Reports Full Year 2025 Financial Results and Provides Business Update | Press release | GlobeNewswire | +0.00% | -4.89% | |
| Form 6-K GH Research PLC For: Jan 22 | SEC filing · Form 6-K | SEC EDGAR | -2.48% | +1.33% | |
| Form 6-K GH Research PLC For: Jan 15 | SEC filing · Form 6-K | SEC EDGAR | +0.06% | +0.65% | |
| Form 6-K GH Research PLC For: Jan 13 | SEC filing · Form 6-K | SEC EDGAR | +2.64% | +4.49% | |
| Form 6-K GH Research PLC For: Jan 08 | SEC filing · Form 6-K | SEC EDGAR | -4.42% | -11.90% | |
| Form 6-K GH Research PLC For: Jan 05 | SEC filing · Form 6-K | SEC EDGAR | -6.16% | -18.59% | |
| GH Research Announces FDA Lifts Clinical Hold on GH001, Clearing Path for Global Phase 3 Initiation in 2026 | Press release | GlobeNewswire | -6.16% | -18.59% | |
| Form 6-K GH Research PLC For: Jan 02 | SEC filing · Form 6-K | SEC EDGAR | -6.16% | -18.59% | |
| GH Research to Announce IND Status for GH001 | Press release | GlobeNewswire | -6.16% | -18.59% | |
| Form 6-K GH Research PLC For: Nov 24 | SEC filing · Form 6-K | SEC EDGAR | -0.04% | +2.97% | |
| Form 6-K GH Research PLC For: Nov 07 | SEC filing · Form 6-K | SEC EDGAR | +1.17% | +1.96% | |
| Form 6-K GH Research PLC For: Sep 30 | SEC filing · Form 6-K | SEC EDGAR | -0.56% | -0.07% | |
| GH Research Reports Third Quarter 2025 Financial Results and Provides Business Updates | Press release | GlobeNewswire | -0.56% | -0.07% | |
| Form 6-K GH Research PLC For: Oct 17 | SEC filing · Form 6-K | SEC EDGAR | +3.70% | -2.25% | |
| Form 6-K GH Research PLC For: Oct 14 | SEC filing · Form 6-K | SEC EDGAR | -0.35% | +4.14% | |
| Form 6-K GH Research PLC For: Oct 10 | SEC filing · Form 6-K | SEC EDGAR | -0.76% | -4.48% | |
| Form 6-K GH Research PLC For: Oct 09 | SEC filing · Form 6-K | SEC EDGAR | -0.73% | -0.98% | |
| GH Research Announces Novel Therapies Symposium Presentation and Posters at the 2025 ECNP Congress | Press release | GlobeNewswire | -0.73% | -0.98% | |
| Form 6-K GH Research PLC For: Sep 12 | SEC filing · Form 6-K | SEC EDGAR | +0.00% | -4.02% | |
| Form 6-K GH Research PLC For: Sep 09 | SEC filing · Form 6-K | SEC EDGAR | +0.00% | -0.07% | |
| Form 6-K GH Research PLC For: Aug 28 | SEC filing · Form 6-K | SEC EDGAR | +0.72% | -2.17% | |
| Form 6-K GH Research PLC For: Jun 30 | SEC filing · Form 6-K | SEC EDGAR | -0.29% | -0.41% | |
| GH Research Reports Second Quarter 2025 Financial Results and Provides Business Updates | Press release | GlobeNewswire | -0.29% | -0.41% | |
| Form 6-K GH Research PLC For: Aug 01 | SEC filing · Form 6-K | SEC EDGAR | +0.64% | -2.97% | |
| Form 20-F/A GH Research PLC For: Dec 31 | SEC filing · Form 20-F | SEC EDGAR | -0.40% | -6.61% | |
| Form 6-K GH Research PLC For: Jul 23 | SEC filing · Form 6-K | SEC EDGAR | -1.31% | -14.88% | |
| GH Research Announces Global Pivotal Program Plans and Further Development Updates | Press release | GlobeNewswire | -1.31% | -14.88% |
Each reaction is the move the market actually made, measured from the news timestamp. Headlines link through to the GHRS section they belong to.
Where else GHRS is measured.
GHRS earnings → · Analyst actions → · SEC filings →
Every ticker we measure the same way24
Apple (AAPL)
How AAPL actually reacts to news, measured.
NVIDIA (NVDA)
How NVDA actually reacts to news, measured.
Tesla (TSLA)
How TSLA actually reacts to news, measured.
Microsoft (MSFT)
How MSFT actually reacts to news, measured.
Advanced Micro Devices (AMD)
How AMD actually reacts to news, measured.
Amazon (AMZN)
How AMZN actually reacts to news, measured.
Alphabet (GOOG)
How GOOG actually reacts to news, measured.
Meta Platforms (META)
How META actually reacts to news, measured.
Broadcom (AVGO)
How AVGO actually reacts to news, measured.
JPMorgan Chase (JPM)
How JPM actually reacts to news, measured.
Visa (V)
How V actually reacts to news, measured.
Walmart (WMT)
How WMT actually reacts to news, measured.
Eli Lilly (LLY)
How LLY actually reacts to news, measured.
UnitedHealth Group (UNH)
How UNH actually reacts to news, measured.
Netflix (NFLX)
How NFLX actually reacts to news, measured.
Johnson & Johnson (JNJ)
How JNJ actually reacts to news, measured.
Exxon Mobil (XOM)
How XOM actually reacts to news, measured.
Home Depot (HD)
How HD actually reacts to news, measured.
Costco (COST)
How COST actually reacts to news, measured.
Mastercard (MA)
How MA actually reacts to news, measured.
Oracle (ORCL)
How ORCL actually reacts to news, measured.
Salesforce (CRM)
How CRM actually reacts to news, measured.
Bank of America (BAC)
How BAC actually reacts to news, measured.
Coca-Cola (KO)
How KO actually reacts to news, measured.
Walt Disney (DIS)
How DIS actually reacts to news, measured.
Browse all tickers
Every name we’ve measured, in one place.
How the numbers are made.
How is GH Research PLC - Ordinary Shares's median reaction calculated?
Every labeled GHRS news event is measured from its own timestamp: the last trade before the news is the base price, and the move is read at fixed horizons — 30 minutes of trading, then the close. The median across 149 events is what this page reports. Point-in-time, zero look-ahead: no event borrows information from a later one.
What counts as a positive reaction?
Any event whose price move is above zero at the horizon, relative to the last trade before the news timestamp. 37% of GHRS's measured events are up at 30 minutes; the rest close the window flat or negative.
How often is this page updated?
The news table refreshes automatically as new events are labeled and priced. The reaction medians are re-pulled in batches from the dataset — the figures here are as of 2026-09-21.
Does GHRS's past reaction predict its next one?
No. These are realized facts about past events, not forecasts. They describe a distribution — they say nothing certain about any future move.